Table 2.

Patient demographic characteristics

Patient ID no.	Sex	Age, y	Ethnicity	Race	Diagnosis	Type of transplant	R/D CMV serostatus	No. of infusions	Days posttransplant
3910	Male	12	Non-Hispanic	African American	Sickle cell anemia	MRD	Negative/positive	1	61
3944	Female	45	Hispanic	White	AML	UCB	Positive/negative	1	197
3976	Male	13	Hispanic	White	ALL	MUD	Positive/positive	2	46
3762	Female	10	Hispanic	White	HLH	MMUD	Positive/negative	1	161
3967	Male	51	Non-Hispanic	White	AML	UCB	Positive/negative	1	365
4091	Male	70	Non-Hispanic	White	CTCL	Haplo	Positive/positive	1	215
4115	Female	3	Non-Hispanic	White	Fanconi anemia	MUD	Positive/positive	1	105
4170	Male	3	Non-Hispanic	African American	Sickle cell anemia	MRD	Negative/positive	1	76
4134	Female	16	Non-Hispanic	White	SCID	MUD	Positive/positive	1	218
4201	Male	11	Non-Hispanic	White	Anaplastic large-cell lymphoma	MUD	Positive/negative	3	70

ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CTCL, cutaneous T-cell lymphoma; Haplo, haploidentical; HLH, hemophagocytic lymphohistiocytosis; MMUD, mismatched unrelated donor; MUD, matched unrelated donor; MRD, matched related donor; R/D, recipient/donor; SCID, severe combined immunodeficiency; UCB, umbilical cord blood.